Connealy Pamela Ann - Insider Non-Derivative Transactions at Pyxis Oncology, Inc. (PYXS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 26, 2024, Connealy Pamela Ann's relationship to Pyxis Oncology, Inc. (PYXS) is Officer (CFO & COO), and currently has 1,110,293 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PYXS insiders.
Data Source: SEC.
Connealy Pamela Ann - Insider Non-Derivative Transactions of PYXS Common Stock
Connealy Pamela Ann - Insider Non-Derivative Transactions at PYXS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 27, 2024 | Acquisition -- (Common Stock) | 328710 | 0 | 1110293 |
| Nov 30, 2023 | F -- (Common Stock) | 36949 | 1.4 | 781583 |
| Sep 29, 2023 | P -- (Common Stock) | 8000 | 1.87 | 818532 |
| Sep 28, 2023 | P -- (Common Stock) | 6426 | 1.85 | 810532 |
| Sep 26, 2023 | P -- (Common Stock) | 12000 | 1.67 | 804106 |
| Sep 23, 2023 | P -- (Common Stock) | 5000 | 1.74 | 792106 |
| Sep 8, 2023 | Acquisition -- (Common Stock) | 187793 | 0 | 782106 |